Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Pharmaron
Pharmaron
Activities:
Research & Development
X
LinkedIn
Trending Articles
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
Broughton receives flexible scope ISO 17025 accreditation
New certification allows accreditation without prior approval
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Research & Development
Pharmaron acquires Quotient Bioresearch
Deal will enhance service offerings and increase presence in global markets
Research & Development
Quotient Bioresearch to sell bioanalytical sciences division to LGC
Acquisition will enable LGC to offer bioanalysis, materials science and reference materials
Research & Development
Quotient Bioresearch opens new £1.5m bioanalytical facility
In response to increased demand for immunoassay and cell-based services from the Fordham, Cambridgeshire-based firm
Research & Development
Quotient Bioresearch expands molecular biology services
Adds Real-Time PCR to support screening of subjects
Manufacturing
Quotient and Capsugel form lipid formulations partnership
Aim to address issues of poor solubility
Research & Development
Management buyout at Quotient Bioresearch
Existing private equity shareholder provides finance
Research & Development
Merck Serono opens r&d laboratory in Beijing
Based on Pharmaron’s new campus
Subscribe now